Ching YP - Search Results

1

P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.

Ching YP, Leong VY, Lee MF, Xu HT, Jin DY, Ng IO. Ching YP, et al. Cancer Res. 2007 Apr 15;67(8):3601-8. doi: 10.1158/0008-5472.CAN-06-3994. Cancer Res. 2007. PMID: 17440071

2

PAK4 Phosphorylates p53 at Serine 215 to Promote Liver Cancer Metastasis.

Xu HT, Lai WL, Liu HF, Wong LL, Ng IO, Ching YP. Xu HT, et al. Among authors: ching yp. Cancer Res. 2016 Oct 1;76(19):5732-5742. doi: 10.1158/0008-5472.CAN-15-3373. Epub 2016 Aug 5. Cancer Res. 2016. PMID: 27496712

3

Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma.

Ching YP, Wong CM, Chan SF, Leung TH, Ng DC, Jin DY, Ng IO. Ching YP, et al. J Biol Chem. 2003 Mar 21;278(12):10824-30. doi: 10.1074/jbc.M208310200. Epub 2003 Jan 16. J Biol Chem. 2003. PMID: 12531887 Free article.

4

Identification of an autoinhibitory domain of p21-activated protein kinase 5.

Ching YP, Leong VY, Wong CM, Kung HF. Ching YP, et al. J Biol Chem. 2003 Sep 5;278(36):33621-4. doi: 10.1074/jbc.C300234200. Epub 2003 Jul 14. J Biol Chem. 2003. PMID: 12860998 Free article.

5

Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma.

Wong CM, Lee JM, Ching YP, Jin DY, Ng IO. Wong CM, et al. Among authors: ching yp. Cancer Res. 2003 Nov 15;63(22):7646-51. Cancer Res. 2003. PMID: 14633684

6

Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.

Wong CM, Yam JW, Ching YP, Yau TO, Leung TH, Jin DY, Ng IO. Wong CM, et al. Among authors: ching yp. Cancer Res. 2005 Oct 1;65(19):8861-8. doi: 10.1158/0008-5472.CAN-05-1318. Cancer Res. 2005. PMID: 16204057 Free article.

7

Role of a novel splice variant of mitotic arrest deficient 1 (MAD1), MAD1beta, in mitotic checkpoint control in liver cancer.

Sze KM, Ching YP, Jin DY, Ng IO. Sze KM, et al. Among authors: ching yp. Cancer Res. 2008 Nov 15;68(22):9194-201. doi: 10.1158/0008-5472.CAN-08-2600. Cancer Res. 2008. PMID: 19010891

8

HAI-2 is epigenetically downregulated in human hepatocellular carcinoma, and its Kunitz domain type 1 is critical for anti-invasive functions.

Tung EK, Wong CM, Yau TO, Lee JM, Ching YP, Ng IO. Tung EK, et al. Among authors: ching yp. Int J Cancer. 2009 Apr 15;124(8):1811-9. doi: 10.1002/ijc.24115. Int J Cancer. 2009. PMID: 19107935

9

Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis.

Mak GW, Chan MM, Leong VY, Lee JM, Yau TO, Ng IO, Ching YP. Mak GW, et al. Among authors: ching yp. Cancer Res. 2011 Apr 15;71(8):2949-58. doi: 10.1158/0008-5472.CAN-10-4046. Epub 2011 Mar 8. Cancer Res. 2011. PMID: 21385901 Free article.

10

The centrosomal protein Tax1 binding protein 2 is a novel tumor suppressor in hepatocellular carcinoma regulated by cyclin-dependent kinase 2.

Lai WL, Hung WY, Wong LL, Zhou Y, Leong VY, Lee JM, Ng IO, Jin DY, Ching YP. Lai WL, et al. Among authors: ching yp. Hepatology. 2012 Nov;56(5):1770-81. doi: 10.1002/hep.25851. Epub 2012 Sep 17. Hepatology. 2012. PMID: 22610972

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters